This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.
Today on the show Technori’s Scott Kitun and Partner with Kelley Drye & Warren LLP Matt Luzadder talk to John Climaco from CNS Pharma, a company working towards developing a drug to battle brain cancer. Scott and Matt also talk to Daniel Downs from R3 Printing, a company revolutionizing 3D printing.
To invest in CNS Pharma click here and to invest in R3 Printing click here.
Make sure to follow Technori on Facebook and Twitter.
